Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gadolinium encephalopathy due to accidental intrathecal administration of gadopentetate dimeglumine.

× No keyword cloud information.

9 in total

1. The association of 14-3-3gamma and actin plays a role in cell division and apoptosis in astrocytes.

Authors: Xiao Qian Chen; Albert Cheung Hoi Yu
Journal: Biochem Biophys Res Commun Date: 2002-08-23 Impact factor: 3.575

2. Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats.

Authors: D E Ray; J B Cavanagh; C C Nolan; S C Williams
Journal: AJNR Am J Neuroradiol Date: 1996-02 Impact factor: 3.825

3. Intrathecal gadolinium (gadopentetate dimeglumine) enhanced magnetic resonance myelography and cisternography: results of a multicenter study.

Authors: E Turgut Tali; Nil Ercan; Gaida Krumina; Mohammed Rudwan; Angel Mironov; Qing Yu Zeng; J Randy Jinkins
Journal: Invest Radiol Date: 2002-03 Impact factor: 6.016

4. Gadolinium encephalopathy in a patient with renal failure.

Authors: Boby Varkey Maramattom; Edward M Manno; Eelco F M Wijdicks; Edward P Lindell
Journal: Neurology Date: 2005-04-12 Impact factor: 9.910

5. Acute and subacute physiological and histological studies of the central nervous system after intrathecal gadolinium injection in the anesthetized rat.

Authors: G M Toney; H A Chavez; R Ibarra; J R Jinkins
Journal: Invest Radiol Date: 2001-01 Impact factor: 6.016

6. Gadolinium enhancement of cerebrospinal fluid in a patient with renal failure.

Authors: S H Erbay; R A Bhadelia
Journal: Neuroradiology Date: 2001-11 Impact factor: 2.804

7. Intrathecal gadolinium-enhanced MR myelography and cisternography: a pilot study in human patients.

Authors: Q Zeng; L Xiong; J R Jinkins; Z Fan; Z Liu
Journal: AJR Am J Roentgenol Date: 1999-10 Impact factor: 3.959

8. Astrocytes in cat visual cortex studied by GFAP and S-100 immunocytochemistry during postnatal development.

Authors: C M Müller
Journal: J Comp Neurol Date: 1992-03-15 Impact factor: 3.215

9. Intrathecal gadolinium (gadopentetate dimeglumine)-enhanced MR cisternography used to determine potential communication between the cerebrospinal fluid pathways and intracranial arachnoid cysts.

Authors: E Turgut Tali; Nil Ercan; Memduh Kaymaz; Aydin Pasaoglu; J Randy Jinkins
Journal: Neuroradiology Date: 2004-09 Impact factor: 2.804

9 in total

19 in total

1. Persistence of gadolinium contrast enhancement in CSF: a possible harbinger of gadolinium neurotoxicity?

Authors: F K Hui; M Mullins
Journal: AJNR Am J Neuroradiol Date: 2008-07-17 Impact factor: 3.825

Review 2. Intrathecal gadolinium-enhanced MR cisternography: a comprehensive review.

Authors: O Algin; B Turkbey
Journal: AJNR Am J Neuroradiol Date: 2012-01-19 Impact factor: 3.825

3. Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.

Authors: B J Edwards; A E Laumann; B Nardone; F H Miller; J Restaino; D W Raisch; J M McKoy; J A Hammel; K Bhatt; K Bauer; A T Samaras; M J Fisher; C Bull; E Saddleton; S M Belknap; H S Thomsen; E Kanal; S E Cowper; A K Abu Alfa; D P West
Journal: Br J Radiol Date: 2014-10 Impact factor: 3.039

4. Gadolinium Aspiration Following Inadvertent Endotracheal Tube Cuff Injection in a Pediatric Patient.

Authors: Ahmed Mamdouh Taha Mostafa; Muhammed Ershad; Maricel Dela Cruz; Rita G McKeever; David Vearrier; Michael I Greenberg
Journal: J Med Toxicol Date: 2019-05-22

5. Neurotoxicity from intrathecal gadolinium administration: Case presentation and brief review.

Authors: Nick Calvo; Marium Jamil; Scott Feldman; Aashit Shah; Feryal Nauman; Joseph Ferrara
Journal: Neurol Clin Pract Date: 2020-02

6. Intrathecal gadolinium-enhanced MR cisternography in patients with otorhinorrhea: 10-year experience of a tertiary referral center.

Authors: Sebahat Nacar Dogan; Osman Kizilkilic; Burak Kocak; Cihan Isler; Civan Islak; Naci Kocer
Journal: Neuroradiology Date: 2018-03-23 Impact factor: 2.804

Review 10. T₁ hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?

Authors: Nigel Hoggard; Giles H Roditi
Journal: Br J Radiol Date: 2016-10-19 Impact factor: 3.039

Gadolinium encephalopathy due to accidental intrathecal administration of gadopentetate dimeglumine.

1. The association of 14-3-3gamma and actin plays a role in cell division and apoptosis in astrocytes.

2. Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats.

3. Intrathecal gadolinium (gadopentetate dimeglumine) enhanced magnetic resonance myelography and cisternography: results of a multicenter study.

4. Gadolinium encephalopathy in a patient with renal failure.

5. Acute and subacute physiological and histological studies of the central nervous system after intrathecal gadolinium injection in the anesthetized rat.

6. Gadolinium enhancement of cerebrospinal fluid in a patient with renal failure.

7. Intrathecal gadolinium-enhanced MR myelography and cisternography: a pilot study in human patients.

8. Astrocytes in cat visual cortex studied by GFAP and S-100 immunocytochemistry during postnatal development.

9. Intrathecal gadolinium (gadopentetate dimeglumine)-enhanced MR cisternography used to determine potential communication between the cerebrospinal fluid pathways and intracranial arachnoid cysts.

1. Persistence of gadolinium contrast enhancement in CSF: a possible harbinger of gadolinium neurotoxicity?

Review 2. Intrathecal gadolinium-enhanced MR cisternography: a comprehensive review.

3. Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.

4. Gadolinium Aspiration Following Inadvertent Endotracheal Tube Cuff Injection in a Pediatric Patient.

5. Neurotoxicity from intrathecal gadolinium administration: Case presentation and brief review.

6. Intrathecal gadolinium-enhanced MR cisternography in patients with otorhinorrhea: 10-year experience of a tertiary referral center.

7. Intrathecal Use of Gadobutrol for Glymphatic MR Imaging: Prospective Safety Study of 100 Patients.

8. An Investigation of Water Diffusivity Changes along the Perivascular Space in Elderly Subjects with Hypertension.

9. Neurotoxic manifestations of an overdose intrathecal injection of gadopentetate dimeglumine.

Review 10. T₁ hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?

Review 2. Intrathecal gadolinium-enhanced MR cisternography: a comprehensive review.

Review 10. T1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?

Review 10. T₁ hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?